Wells Fargo & Company En V Veno Medical Corp Call Options Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVNO
# of Institutions
42Shares Held
5.61MCall Options Held
89.3KPut Options Held
5.2K-
Kingdon Capital Management, L.L.C. New York, NY859KShares$2.71 Million0.35% of portfolio
-
Perceptive Advisors LLC New York, NY694KShares$2.19 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT597KShares$1.88 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$1.86 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL425KShares$1.34 Million0.01% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $29.8M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...